Efficacy of pre-hospital use of glycoprotein IIb/IIIa inhibitors in ST-segment elevation myocardial infarction before mechanical reperfusion in a rapid-transfer network (from the acute myocardial infarction registry of Brittany)

American Journal of Cardiology

Volumn 114, Issue 2, 2014, Pages 214-223

  Auffret, Vincent ^a,b   Oger, Emmanuel ^a   Leurent, Guillaume ^a,b   Filippi, Emmanuelle ^c   Coudert, Isabelle ^a   Hacot, Jean Philippe ^d   Castellant, Philippe ^e   Rialan, Antoine ^f   Delaunay, Régis ^g   Rouault, Gilles ^h   Druelles, Philippe ⁱ   Boulanger, Bertrand ^j   Treuil, Josiane ^e   Avez, Bertrand ^k   Bedossa, Marc ^a,b   Boulmier, Dominique ^a,b   Le Guellec, Marielle ^a,b   Le Breton, Hervé ^a,b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c Service de Cardiologie   (France)

^d Service de Cardiologie   (France)

^e BREST UNIVERSITY HOSPITAL   (France)

^f CH de Saint Malo Service de Cardiologie   (France)

^g CH Saint Brieuc   (France)

^h CH Quimper   (France)

ⁱ Clinique Saint Laurent   (France)

^j CH de Vannes SAMU   (France)

^k SAMU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; TIROFIBAN;

ADULT; BLOOD CLOT LYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; EMERGENCY CARE; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AMBULANCES; ANTERIOR WALL MYOCARDIAL INFARCTION; CORONARY ANGIOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION; OUTPATIENTS; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REGISTRIES; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84903125008     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.04.029     Document Type: Conference Paper

References (30)

1. P.G. Steg, S.K. James, D. Atar, L.P. Badano, C. Blömstrom-Lundqvist, M.A. Borger, C. Di Mario, K. Dickstein, G. Ducrocq, F. Fernandez-Aviles, A.H. Gershlick, P. Giannuzzi, S. Halvorsen, K. Huber, P. Juni, A. Kastrati, J. Knuuti, M.J. Lenzen, K.W. Mahaffey, M. Valgimigli, A. van't Hof, P. Widimsky, D. Zahger Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
2. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 36 2003 13 20 (Pubitemid 36050955)
3. G. De Luca, H. Suryapranata, J.P. Ottervanger, and E.M. Antman Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts Circulation 109 2004 1223 1225 (Pubitemid 38372780)
4. G. De Luca, E. Navarese, and P. Marino Risk profile and benefits from GP IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials Eur Heart J 30 2009 2705 2713
5. A.W. Van't Hof, J. Ten Berg, T. Heestermans, T. Dill, R.C. Funck, W. van Werkum, J.H. Dambrink, H. Suryapranata, G. van Houwelingen, J.P. Ottervanger, P. Stella, E. Giannitsis, and C. Hamm Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (ON-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 2008 537 546
6. D. Dudek, Z. Siudak, M. Janzon, R. Birkemeyer, G. Aldama-Lopez, C. Lettieri, B. Janus, A. Wisniewski, S. Berti, Z. Olivari, T. Rakowski, L. Partyka, J. Goedicke, and K. Zmudka European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab - EUROTRANSFER Registry Am Heart J 156 2008 1147 1154
7. G. De Luca, C.M. Gibson, F. Bellandi, S. Murphy, M. Maioli, M. Noc, U. Zeymer, D. Dudek, H.R. Arntz, S. Zorman, H.M. Gabriel, A. Emre, D. Cutlip, G. Biondi-Zoccai, T. Rakowski, M. Gyongyosi, P. Marino, K. Huber, and A.W. van't Hof Early Glycoprotein IIb-IIIa Inhibitors in Primary Angioplasty (EGYPT) cooperation: an individual patient data meta-analysis Heart 94 2008 1548 1558
8. Q. Xu, J. Yin, and L.Y. Si Efficacy and safety of early versus late glycoprotein GPI for PCI Int J Cardiol 162 2013 210 219
9. S.G. Ellis, M. Tendera, M.A. de Belder, A.J. van Boven, P. Widimsky, L. Janssens, H.R. Andersen, A. Betriu, S. Savonitto, J. Adamus, J.Z. Peruga, M. Kosmider, O. Katz, T. Neunteufl, J. Jorgova, M. Dorobantu, L. Grinfeld, P. Armstrong, B.R. Brodie, H.C. Herrmann, G. Montalescot, F.J. Neumann, M.B. Effron, E.S. Barnathan, and E.J. Topol Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217 (Pubitemid 351724450)
10. J. Mehilli, A. Kastrati, S. Schulz, S. Früngel, S.G. Nekolla, W. Moshage, F. Dotzer, K. Huber, J. Pache, J. Dirschinger, M. Seyfarth, S. Martinoff, M. Schwaiger, and A. Schömig Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial Circulation 119 2009 1933 1940
11. F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, A. Kastrati, A. Rosengren, P.G. Steg, M. Tubaro, F. Verheugt, F. Weidinger, and M. Weis Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
12. J. Silvain, J.P. Collet, C. Nagaswami, F. Beygui, K.E. Edmondson, A. Bellemain-Appaix, G. Cayla, A. Pena, D. Brugier, O. Barthelemy, G. Montalescot, and J.W. Weisel Composition of coronary thrombus in acute myocardial infarction J Am Coll Cardiol 57 2011 1359 1367
13. T. Heestermans, A.W. van 't Hof, J.M. ten Berg, J.W. van Werkum, E. Boersma, A. Mosterd, P.R. Stella, A.B. van Zoelen, A.T. Gosselink, W. Kochman, T. Dill, P.C. Koopmans, G. van Houwelingen, F. Zijlstra, and C. Hamm The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (ON-TIME 2) trial early initiation of triple antiplatelet therapy Am Heart J 160 2010 1079 1084
14. M. Maioli, F. Bellandi, M. Leoncini, A. Toso, and R.P. Dabizzi Randomized Early Versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial) J Am Coll Cardiol 49 2007 1517 1524 (Pubitemid 46517954)
15. K. Huber, D.R. Holmes Jr., A.W. van 't Hof, G. Montalescot, P.E. Aylward, G.A. Betriu, P. Widimsky, C.M. Westerhout, C.B. Granger, and P.W. Armstrong Use of glycoprotein GPI in primary percutaneous coronary intervention: insights from the APEX-AMI trial Eur Heart J 31 2010 1708 1716
16. P. Ortolani, A. Marzocchi, C. Marrozzini, T. Palmerini, F. Saia, N. Taglieri, F. Baldazzi, G. Dall'Ara, P. Nardini, S. Gianstefani, P. Guastaroba, R. Grilli, and A. Branzi Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network Eur Heart J 30 2009 33 43
17. P.J. Vlaar, T. Svilaas, K. Damman, B.J. de Smet, J.G. Tijssen, H.L. Hillege, and F. Zijlstra Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review Circulation 118 2008 1828 1836
18. U. Zeymer, H.R. Arntz, B. Mark, S. Fichtlscherer, G. Werner, R. Schöller, R. Zahn, F. Diller, H. Darius, T. Dill, and K. Huber Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial Clin Res Cardiol 101 2012 305 312
19. C. El Khoury, P.Y. Dubien, C. Mercier, L. Belle, G. Debaty, O. Capel, T. Perret, D. Savary, P. Serre, and E. Bonnefoy Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study Arch Cardiovasc Dis 103 2010 285 292
20. M.R. Le May, G.A. Wells, C.A. Glover, D.Y. So, M. Froeschl, J.F. Marquis, E.R. O'Brien, M. Turek, A. Thomas, M. Kass, S. Jadhav, and M. Labinaz Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST) Circ Cardiovasc Interv 4 2009 330 338
21. T. Jernberg, C.D. Payne, K.J. Winters, C. Darstein, J.T. Brandt, J.A. Jakubowski, H. Naganuma, A. Siegbahn, and L. Wallentin Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease Eur Heart J 27 2006 1166 1173
22. G.J. Weerakkody, J.A. Jakubowski, J.T. Brandt, N.A. Farid, C.D. Payne, J. Zhu, M.R. Warner, H. Naganuma, and K.J. Winters Comparison of speed of onset of platelet inhibition after loading doses of clopidogrel versus prasugrel in healthy volunteers and correlation with responder status Am J Cardiol 100 2007 331 336 (Pubitemid 47042002)
23. G. Montalescot, S.D. Wiviott, E. Braunwald, S.A. Murphy, C.M. Gibson, C.H. McCabe, and E.M. Antman Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
24. P.G. Steg, S. James, R.A. Harrington, D. Ardissino, R.C. Becker, C.P. Cannon, H. Emanuelsson, A. Finkelstein, S. Husted, H. Katus, J. Kilhamn, S. Olofsson, R.F. Storey, W.D. Weaver, and L. Wallentin Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis Circulation 122 2010 2131 2141
25. V. Kunadian, S.K. James, D.M. Wojdyla, C. Zorkun, J. Wu, R.F. Storey, P.G. Steg, H. Katus, H. Emanuelsson, J. Horrow, J. Maya, L. Wallentin, R.A. Harrington, and C.M. Gibson Angiographic outcomes in the PLATO trial (Platelet Inhibition and Patient Outcomes) JACC Cardiovasc Interv 6 2013 671 683
26. G. Parodi, R. Valenti, B. Bellandi, A. Migliorini, R. Marcucci, V. Comito, N. Carrabba, A. Santini, G.F. Gensini, R. Abbate, and D. Antoniucci Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study J Am Coll Cardiol 61 2013 1601 1606
27. D. Alexopoulos, I. Xanthopoulou, V. Gkizas, G. Kassimis, K.C. Theodoropoulos, G. Makris, N. Koutsogiannis, A. Damelou, G. Tsigkas, P. Davlouros, and G. Hahalis Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction Circ Cardiovasc Interv 5 2012 797 804
28. P.W. Armstrong, H. Siha, Y. Fu, C.M. Westerhout, P.G. Steg, S.K. James, R.F. Storey, J. Horrow, H. Katus, P. Clemmensen, R.A. Harrington, and L. Wallentin ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy Circulation 125 2012 514 521
29. A.B. Greenbaum, E.M. Ohman, C.M. Gibson, S. Borzak, A.L. Stebbins, M. Lu, M.R. Le May, J.E. Stankowski, H. Emanuelsson, and W.D. Weaver Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial Am Heart J 154 2007 702 709 (Pubitemid 47449634)
30. P.G. Steg, A. van 't Hof, C.W. Hamm, P. Clemmensen, F. Lapostolle, P. Coste, J. Ten Berg, P. Van Grunsven, G.J. Eggink, L. Nibbe, U. Zeymer, M. Campo dell' Orto, H. Nef, J. Steinmetz, L. Soulat, K. Huber, E.N. Deliargyris, D. Bernstein, D. Schuette, J. Prats, T. Clayton, S. Pocock, M. Hamon, P. Goldstein EUROMAX Investigators Bivalirudin started during emergency transport for primary PCI N Engl J Med 369 2013 2207 2217